Cannabinoid and terpene combination

This page covers all Cannabinoid and terpene combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CB2 receptor, TRPV1, 5-HT1A, GPR55.

Targets

CB2 receptor, TRPV1, 5-HT1A, GPR55

Phase 3 pipeline (1)

• Cannabidiol and β-Caryophyllene Patch · Humanitas Clinical and Research Center · Pain Management, Neurology, Dermatology
  Cannabidiol and β-caryophyllene work synergistically through cannabinoid and terpene receptors to modulate pain, inflammation, and potentially neuropathic signaling.

Patent intelligence

• cannabinoid and terpene combination patent landscape — aggregated cliff calendar, attackable patents, originator estates